Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

YouTube

Bladder Cancer Clinical Updates and Highlights from ASCO GU 2024

Dana-Farber Cancer Institute via YouTube

Start learning Write review
OpenLearning Ad

Future-Proof Your Career: AI Manager Masterclass

Learn More → Boot.dev Ad

The Most Addictive Python and SQL Courses

Learn More →

Overview

Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Watch a comprehensive clinical update presentation from Dana-Farber Cancer Institute's Lank Center for Genitourinary Oncology covering the latest bladder cancer research findings and trial results from ASCO GU 2024. Learn about key developments including the Ambassador Trial, EV32 Trial, and UPF Front Trial, gaining valuable insights into the latest advancements in bladder cancer treatment and clinical outcomes. Explore detailed analysis and expert commentary on these significant trials that are shaping the future of genitourinary oncology in this 23-minute educational session.

Syllabus

Intro
Ambassador Trial
EV32 Trial
UPF Front Trial
Comments

Taught by

Dana-Farber Cancer Institute

Reviews

Start your review of Bladder Cancer Clinical Updates and Highlights from ASCO GU 2024

Start learning

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Sign up for free
Someone learning on their laptop while sitting on the floor.